Vorinostat has been shown to inhibit the differentiation, maturation, and endocytosis of human CD14(+) monocyte-derived dendritic cells and further inhibit their stimulation of allogeneic T-cell proliferation, thereby ameliorating experimental autoimmune encephalomyelitis [15]. This evidence concerns the gene CD14 and experimental autoimmune encephalomyelitis.